TAMMY DANIEL: Open Payments
NPI 1871221127 · LAKE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,742 in 75 payments from 32 companies in 2025. Trend: 2023 $0 · 2024 $2,312 · 2025 $1,742
Food & beverage: $1,620Education: $122
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $216 |
| AstraZeneca Pharmaceuticals LP | 8 | $186 |
| SOBI, INC | 2 | $114 |
| GlaxoSmithKline, LLC. | 5 | $96 |
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $80 |
| Janssen Biotech, Inc. | 4 | $79 |
| Novartis Pharmaceuticals Corporation | 4 | $68 |
| Celgene Corporation | 3 | $68 |
| PFIZER INC. | 3 | $61 |
Products named: KEYTRUDA, OPDIVO, Nubeqa, REBLOZYL, IMFINZI, OJJAARA, LONSURF, BESREMI.
Industry payments across FL — which companies pay providers there.
